Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1565
Title: ASSESSMENT OF ADHERENCE TO 6- MERCAPTOPURINE IN MAINTENANCE PHASE CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA- A PROSPECTIVE INTERVENTIONAL STUDY
Authors: REGNO:BM0120004
Issue Date: 2023
Publisher: KLE Academy of Higher Education and Research, Belagavi
Abstract: Background and aims 6 mercaptopurine (MP) forms backbone of maintenance chemotherapy for ALL, which typically lasts for 2 to 2.5 years. As with any long-term therapy, poor adherence is serious impediment in 6 MP maintenance treatment, which may impact outcome. Indeed, COG study found 3.9 fold increased risk of relapse in children with 6 MP adherence of less than 90%. There are no studies regarding adherence to 6MP from India. Hence, we studied prevalence of non- adherence to 6 MP and impact of use of electronic pill box on it, in our cohort on maintenance chemotherapy
URI: http://localhost:8080/xmlui/handle/123456789/1565
Appears in Collections:Pediatrics MD

Files in This Item:
File Description SizeFormat 
BM0120004.pdf2.1 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.